NCT04164966View on ClinicalTrials.gov

Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes

Active, not recruitingOBSERVATIONAL

Enrollment

28

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

July 23, 2024

Study Completion Date

December 31, 2025

Conditions

Type 1 Diabetes

Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors

lead

AdventHealth Translational Research Institute

OTHER